The Lancet Microbe in conversation with
Editors at The Lancet Microbe, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from using probiotics to reduce Staphylococcus aureus, to phage therapy and monitoring antimicrobial resistance using faecal metagenomes, and more.
Episodes
16 episodes
Laurence Armand-Lefevre and Luc Samison on surveillance of antimicrobial resistant Escherichia coli in humans, chickens, and the environment in Madagascar
Rebecca Barksby of The Lancet Microbe speaks to Professor Laurence Armand-Lefevre and Professor Luc Hervé Samison about implementing the WHO Tricycle Protocol in Madagascar for the surveillance of extended-spectrum β-lactamase producing Escheri...
•
25:36
Zoe Dyson and Philip Ashton on Salmonella enterica serotypes Typhi and Paratyphi A
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Zoe Dyson and Dr Philip Ashton about the genomic characterisation of population diversity, antimicrobial resistance profiles, and transmission patterns of Salmonella enterica serot...
•
30:31
Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh on Streptococcus pyogenes
Elena Dalla Vecchia of The Lancet Microbe speaks to Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh about Streptococcus pyogenes carriage and transmission in households in The Gambia.Read the full article:
•
26:25
Martin Hoenigl on climate change and fungal diseases
Rebecca Barksby of The Lancet Microbe speaks with Professor Martin Hoenigl about the impact of climate change and natural disasters on fungal diseases.Read the full article:
•
35:18
Nancy Chow on sporotrichosis
Rebecca Barksby of The Lancet Microbe speaks to Dr Nancy Chow about sporotrichosis and discusses a genomic epidemiology study of this zoonotic fungal disease among people and cats in Brazil.Read the full article:
•
21:25
Deborah Williamson and Michael Moso on detecting on-SARS-CoV-2 viruses from COVID-19 rapid antigen test devices
Elena Dalla Vecchia of The Lancet Microbe speaks to Deborah Williamson and Michael Moso about non-SARS-CoV-2 respiratory viral detection from COVID-19 rapid antigen test devices.Read the full article:
•
19:01
Kate Baker on harnessing genomics for antimicrobial resistance surveillance
Rebecca Barksby of The Lancet Microbe speaks to Professor Kate Baker about the challenges, potential, and recommendations for using genomics to monitor antimicrobial resistance.Read the full Series:
•
19:19
Erica Furhmeister on monitoring antimicrobial resistance using faecal metagenomes
Rebecca Barksby of The Lancet Microbe talks to Dr Erica Furhmeister about monitoring antimicrobial resistance using faecal metagenomes.Read the full article:
•
18:44
Jie Zhou and Anika Singanayagam on their SARS-CoV-2 human challenge study
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Jie Zhou and Dr Anika Singanayagam about their SARS-CoV-2 human challenge study.Read the full article:
•
19:50
Hanna Ehrlich on antimalarial drug resistance surveillance
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Hanna Ehrlich about antimalarial drug resistance surveillance and her recent cross-sectional study using xenomonitoring in Burkina Faso.Read the full article:
•
31:16
Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludiques (en français)
Elena Dalla Vecchia du The Lancet Microbe converse avec Dr Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludique et son étude récent qui a utilisé la xenosurveillance en Burkina Faso.Pour lire l’articl...
•
31:13
Nichola Calvani on gender equity in science
Rebecca Barksby of The Lancet Microbe talks to Dr Nichola Calvani about gender equity in science and Herminthology, an online initiative that produces online profiles of women working in parasitology.
•
21:10
Michael Otto on using probiotics to reduce Staphylococcus aureus
Rebecca Barksby of The Lancet Microbe talks to Dr Michael Otto and his and his collaborators’ placebo-controlled phase 2 trial that used the probiotic Bacillus subtilis to reduce Staphylococcus aureus in adults who we...
•
19:38
David Cameron on phage therapy
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr David Cameron about phage therapy and his and his colleagues’ recent systematic review and meta-analysis of the efficacy of phage therapy in preclinical models of bacterial infecti...
•
8:32
Samuel Lipworth on Mycobacterium abscessus
Jonathan Blott talks to Dr Samuel Lipworth about his and his collaborators' investigation of the epidemiology of Mycobacterium abscessus in England and the risk of person-to-person transmission in health-care settings
•
12:20
Adrian Martineau on Mycobacterium tuberculosis in Ethiopia
Rachel Hellier talks to Prof Adrian Martineau about his and his collaborators’ study that identified Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic individuals in Ethiopia, a ...
•
13:07